Clinical Trial Update: Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating erectile dysfunction improvement with fluvastatin in men with cardiovascular risk factors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Fluvastatin (fluvastatin)

Snippet

Sponsor: University Hospital, Saarland | Conditions: Impotence | Phase 3 | Status: WITHDRAWN